Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 5 (3%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN | 4MG | SOLUTION | Resolved | 2019-12-16 | 2020-01-30 | 101443 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-12-19 | 2020-01-15 | 101768 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-12-19 | 2020-04-17 | 101771 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-07 | 2020-03-03 | 102494 |
| DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-01-13 | 2020-02-26 | 103178 |
| DIOVAN 160MG TABLETS | 160MG | TABLET | Resolved | 2020-01-13 | 2020-03-20 | 103181 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-01-20 | 2020-04-17 | 103742 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-01-20 | 2020-03-31 | 103745 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-02-21 | 2020-04-21 | 106958 |
| DIOVAN | 40MG | TABLET | Resolved | 2020-03-09 | 2020-04-17 | 108259 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-03-31 | 2020-04-21 | 110235 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2020-04-20 | 2020-09-08 | 112537 |
| DIOVAN | 320MG | TABLET | Resolved | 2020-04-22 | 2020-05-05 | 112809 |
| DIOVAN | 40MG | TABLET | Resolved | 2020-04-22 | 2020-05-21 | 112812 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-04-27 | 2020-05-21 | 113330 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2020-05-05 | 2020-06-17 | 114093 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114097 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114100 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-05-21 | 2020-08-28 | 115462 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |